ArticleBMC cancer2013

Potentiation of in vitro and in vivo antitumor efficacy of doxorubicin by cyclin-dependent kinase inhibitor P276-00 in human non-small cell lung cancer cells.

Maggie J Rathos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.